← Leaderboards
Thanh-Trang Vo
Harvard Medical School
$167,404
Attributed
$167,404
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $56K · FY2010–15$100K$75K$50K$25K$0
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$167,404 · 2
By mechanism
F32$109,324 · 1
F31$58,080 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Georgia Stirtz$82,366
- Catherine Sodroski$105,276
- Zachary Mark Augur$122,052
- Ellen Yu$129,779
- Nicole A Cohen$44,567
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsDrug ResistanceResponseCellsChemotherapyResistancePharmaceutical PreparationsSignal TransductionKillingsMitochondriaCell LineApoptoticCancer CellRelapseCessation Of LifeCancer TypeProtein FamilyCell SurvivalChemotherapeutic AgentPublic Health RelevancePathway InteractionsAffectApoptosisIn Vitro
Grant awards (4)
Unleashing the Efficacy of PI3K/AKT/mTOR Pathway Inhibitors in B-ALL$56,042
F32 · FY2015 · CA · contact PI
Unleashing the Efficacy of PI3K/AKT/mTOR Pathway Inhibitors in B-ALL$53,282
F32 · FY2014 · CA · contact PI
Mitochondrial Apoptotic Sensitivity in Predicting Acute Myeloid Leukemia Response$25,444
F31 · FY2011 · CA · contact PI
Mitochondrial Apoptotic Sensitivity in Predicting Acute Myeloid Leukemia Response$32,636
F31 · FY2010 · CA · contact PI